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The plasma membranes of phagocytic leukocytes have receptors for the Fc portion 
of IgG (1-6)  and for a  cleavage product of the third component of complement, C3 
(3,  4,  6-8).  These receptors are distinct  from one another  (1-3)  and serve different 
functions  in  promoting  the  interaction  of phagocytic  cells  with  immunologically 
coated  particles  and  soluble  material  in  the  cells'  environment  (6-10).  Several 
investigators have demonstrated that the C3b receptors of mouse peritoneal macro- 
phages  (6-9)  and other phagocytic cells  (11)  mediate binding,  but  not  ingestion, of 
C3b-coated particles. Bianco et al.  (8)  have previously found that the C3b receptors 
of  mouse  peritoneal  macrophages  elicited  by  the  i.p.  injection  of  thioglycollate 
medium  mediate  both  binding  and  ingestion  of C3b-coated  particles.  It  was  not 
possible in those studies to determine whether thioglycollate medium altered macro- 
phage  complement  receptor  function  by  inducing  the  influx  of a  physiologically 
different population of mononuclear phagocytes into the peritoneal cavity, by altering 
the number or density of complement receptors of resident  peritoneal macrophages, 
or by inducing a  qualitative change in the function of complement receptors of the 
resident macrophage population. 
To  understand  better  the  cellular  and  molecular  mechanisms  by  which  such 
changes  in  complement  receptor  function  may  occur  in  vivo,  we  undertook  to 
determine the in vitro conditions  under which  the function of macrophage comple- 
ment receptors could be modified. Because available evidence suggests that thiogly- 
collate-elicited macrophages behave similarly in many respects to macrophages that 
have been  influenced  by  lymphokines  (12-15),  our  initial  efforts  were  directed  at 
examining  the  effects  of antigen-stimulted  lymphocytes  and  their  products  upon 
macrophage complement receptor function.  However, in experiments in which  lym- 
phocytes and  macrophages from bacille Calmette Gu~rin-infected  mice were culti- 
vated together in the presence of appropriate antigen, we were unable to detect any 
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alteration  of macrophage complement receptor function  (J.  A.  Griffin and  F.  M. 
Griffin, unpublished observations). 
A variety of soluble factors that influence macrophage behavior has been described 
previously (16). For the most part, these products are elaborated by T  lymphocytes 
and alter aspects of macrophage function as diverse as motility (17-20), glucose and 
Oxygen uptake and metabolism (14, 15, 21), cytotoxicity (22, 23), phagocytic activity 
(14,  15, 24), microbicidal and microbistatic capability (25-27), protease secretion (28- 
30),  and  the interactions of macrophages with  other lymphocyte populations  (31). 
The requirements for the generation of these T-lymphocyte products are generally 
unique  to  the  specific  product  and  to  the  macrophage  function  affected.  Some 
lymphocyte products are elaborated only after a  signal  is received by lymphocytes 
from macrophages or macrophage products (31-33); in one experimental system, only 
macrophages  that  had  recently engaged  in  phagocytosis  were  able  to  impart  the 
necessary signal (31, 32). 
In this paper, we report the results of  experiments in which macrophage complement 
receptor function may be converted in vitro from mediating only particle binding to 
promoting both binding and ingestion of complement-coated particles.  Our results 
show that a T-lymphocyte product is responsible for the observed change in macro- 
phage complement receptor function. To elaborate the product,  lymphocytes must 
receive a signal, not from an antigen, but from macrophages that have been triggered 
by phagocytosis of IgG-containing immune complexes. The findings presented may 
have physiologic relevance, because the in vitro conditions required to effect enhanced 
complement receptor activity are similar to the conditions thought to prevail at sites 
of inflammation in vivo. 
Materials and Methods 
Reagents and Media.  Glutaraldehyde, 50% aqueous solution (Fisher Scientific Co., Pittsburgh, 
Pa.); sheep erythrocytes (E) 1 (Animal Blood Center, Syracuse, N.Y.)~ polystyrene latex beads, 
1.1/~ in Diam (Dow Corning Corp., Midland, Mich.); fetal bovine serum (FBS) and freshly 
frozen guinea pig serum  (Grand Island  Biological Co., Grand Island,  N.  Y.);  Medium  199 
(medium)  (Microbiological  Associates, Walkersville,  Md.);  and Ficoll-Hypaque (Pharmacia 
Fine Chemicals,  Div. of Pharmacia, Inc., Piscataway,  N. J.) were obtained from the manufac- 
turers as indicated. FBS was decomplemented by heating at 56°C for 30 min before use. Brewer 
thioglycollate  medium was obtained from Difco Laboratories, Detroit, Mich.; a 4.05% aqueous 
solution was prepared according to the manufacturer's directions.  Lyophilized rabbit gamma 
globulin  (N. L. Cappel Laboratories Inc., Cochranville,  Pa.)  was reconstituted in phosphate- 
buffered saline (PBS) at a concentration of 10 mg/ml; a portion of the reconstituted material 
was aggregated at 63°C for 45 min (34). Lyophilized human serum albumin (HSA, recrystal- 
lized five times, Sigma Chemical Co., St. Louis, Mo.) was reconstituted in PBS at a concentra- 
tion of 20 mg/ml. 
Antibody Preparations.  Rabbit anti-sheep  E IgG and rabbit anti-sheep  E IgM were obtained 
from Cordis Laboratories Inc., Miami, Fla. Rabbit antiserum against  the capsular polysaccha- 
ride of type 1 Streptococcus pneumoniae was obtained from the New York State Department of 
Health, Albany, N.  Y.  Rabbit  anti-ox E  IgG was  a  gift  from Dr.  E.  Pearl,  University of 
1 Abbreviations used in this paper." AI, attachment index; E, erythrocytes; E(IgG), E coated with anti-E IgG; 
E(IgG)C, E(IgG) coated with the first four complement components; E(IgM), E coated with anti-E IgM; 
E(IgM)C, E(IgM) coated with the first four complement components; E(IgM)C3d, E(IgM)C incubated for 
1 h  with a  source of C3b inactivator; FBS, fetal bovine serum; HSA, human serum albumin; medium, 
Medium  199; oxE(IgG),  0.5%  ox  E  coated  with  anti-ox  E  [gG;  PBS,  phosphate-buffered saline;  PI, 
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Alabama  in  Birmingham,  Birmingham, Ala.  Fluorescein-tagged goat  anti-mouse /~-chain 
antibody was  a  gift  from  Dr.  A.  Lawton,  University of Alabama in  Birmingham. It  was 
prepared  by  immunizing a  goat  with  purified  mouse  myeloma IgM;  anti-mouse /~-chain 
antibodies were purified by immunoselection of the antiserum on Sepharose 4B  (Pharmacia 
Fine Chemicals, Div. of Pharmaeia, Inc.) (35). Rhodamine-tagged rabbit anti-rat thymocyte 
IgG was a gift from Dr. C. Balch, University of Alabama in Birmingham. It was prepared by 
immunizing  a rabbit with rat thymocytes and selecting the IgG fraction of the antiserum (36). 
The speeificlty of the resulting preparation for mouse thymoeytes and T  lymphocytes has been 
previously documented (37). Rabbit anti-mouse Thy-1 antiserum, kindly provided by Dr. R. 
Zwerner, University of Alabama in Birmingham, was raised in a rabbit against purified Thy- 
1 preparations from the T-cell lymphoma BW5147.  Its specificity for mouse thymocytes and T 
lymphocytes has been previously demonstrated (38). Rabbit anti-HSA antiserum was  a  gift 
from S. Jackson, University of Alabama in Birmingham.; it was heat decomplemented (56°C, 
30 min) before use. 
Preparation  of  Antibody- and  Complement-coated Sheep E.  E,  E  coated  with  anti-E  IgM 
(E[IgM]),  E(IgM)  coated  with  the  first  four complement components (E[IgM]C),  2 E(IgM) 
incubated for  1 h  with a  source of C3d inactivator (E[IgM]C3d), E coated with anti-E IgG 
(E[IgG]),  and  E(IgG)  coated  with  the  first  four  complement components (E[IgG]C)  were 
prepared as previously described (7, 8). 
Preparation of Antibody-coated Ox E.  Anti-ox E  IgG was found to have an opsonic titer for 
sheep E at a dilution of 1:256. It was therefore absorbed with a  50%  (vol/vol) suspension of 
sheep E at 37°C for 1 h, after which it was unable to promote either attachment or ingestion 
of E or ingestion of E(IgM)C by normal macrophages. Because very low concentrations of IgG 
have been shown to promote the ingestion of particles coated with C3b (9), our finding that the 
absorbed antibody preparation was  unable to  induce the  ingestion of E(IgM)C by normal 
macrophages  indicates that  anti-sheep E  antibodies had  been thoroughly removed  by  the 
absorption procedure. The preparation retained full opsonic activity for ox E. 
1 ml of 2% (vol/vol) ox E in medium was incubated with an equal volume ofa 1  : 128 dilution 
of absorbed anti-ox E IgG for 15 min at 37°C. The suspension was centrifuged for 5 min at 750 
g, and the pelleted E were suspended in medium at a concentration of 0.5%. This preparation, 
0.5% ox E coated with anti-ox E IgG, is designated oxE(IgG). 
Preparation of Soluble Immune Complexes.  1 ml of anti-HSA antiserum was incubated with 10 
mg of HSA for 1 h at 37°C. Although the exact antigen-antibody  ratio cannot be determined, 
the  mixture contained an excess  of antigen, the  estimated molar ratio being at  least  10:1, 
assuming 25%  of the IgG in the antiserum was specific  for  HSA.  No precipitates of a  size 
sufficient to cloud the solution were formed. 
Animals.  20- to 30-g female mice (strain CD-1) were obtained from Charles River Breeding 
Laboratories, Inc., Wilmington, Mass.; female BALB/c mice and congenitally athymic (nu/ 
nu) BALB/c mice were obtained from Dr. J. McGhee, University of Alabama in Birmingham.; 
and female C57BL/6 mice were obtained from The Jackson Laboratory, Bar Harbor, Maine. 
These strains served as sources  of peritoneal macrophages and of splenic, mesenteric lymph 
node,  and  thymic  lymphocytes.  Female C5-deficient AKR  mice  were  obtained  from  The 
Jackson  Laboratory and were  used  as  sources  of C5-deficient mouse serum,  as  previously 
described (7). 
Macrophages.  Mouse  peritoneal  macrophages  were  harvested  by  peritoneal  lavage  and 
cultivated in 35-mm Petri dishes with or without  13-mm Diam glass cover slips  in medium 
alone or  medium containing 20%  FBS,  as  previously described  (7). Thioglycollate-elicited 
macrophages were harvested 4 d after i.p.  injection of 1 ml/mouse of thioglycollate medium 
and cultivated under conditions identical to those described for nonelicited macrophages. 
Lymphocytes.  Lymphocytes were  harvested  from  mouse spleens, mesenteric lymph nodes, 
and thymi as previously described (39). More than 98% of the harvested cells were lymphocytes, 
as determined by morphology and their inability  to phagocytize polystyrene latex beads; >95% 
of the cells were viable, as judged by trypan blue dye exclusion. 
Populations of iymphocytes enriched in B lymphocytes were prepared by two methods: (a) 
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splenic tymphocytes were incubated in medium at a concentration of 2  ×  107 per ml at 4°C for 
30  rain  with  a  1:20  dilution  of anti-Thy-1  antiserum.  Cells  were  washed,  resuspended  in 
medium containing 5% fresh guinea pig serum as a  complement source, and incubated  for  15 
min at  37°C.  Cold medium  was added  and  the cells were suspended  in Tris buffer,  layered 
onto Ficoll-Hypaque, and centrifuged at  400 g  for 40 min at  25°(2 to remove dead cells and 
cellular debris. The cells in the buffer-Ficoll-Hypaque interface were washed and resuspended 
in medium.  (b)  Splenic lymphocytes from congenitally athymic (nu/nu)  BALB/c mice served 
as a  second source of B-enriched lymphocytes. 
Populations  of lymphocytes  enriched  in  T  lymphocytes  were  prepared  in  the  following 
manner. Splenic lymphocytes (1  ×  106 per ml) were incubated with  1.0%  E(IgG)(2 for 15 min 
at  37°(2.  3  ml of each  lymphocyte-E suspension  was  layered  onto  a  3-ml  cushion  of Ficoll° 
Hypaque in 15-mm,Diam glass tubes and centrifuged at 400 g for 40 min at 25°(2. The cellular 
pellicles at  the medium-Ficoll-Hypaque interface were gently aspirated,  washed  in  medium, 
and resuspended in medium or in medium-FBS at a concentration of 1 ×  107 cells per ml. The 
interface cells contained <3% lymphocytes which, on retesting, bound three or more E(IgG)C. 
Bacteria.  S. pneumoniae type 1 was kindly provided by Dr. H. Dillon, University of Alabama 
in Birmingham.  The bacteria were maintained,  passed  in mice, and cultivated as previously 
described  (7).  Some pneumococci  were opsonized  by incubating  1-2  ×  108 organisms with 
heat-inactivated (56°(2, 30 min) anti-capsular antiserum  (180/tg protein)  in 1 ml of medium at 
4°(2 for 30 min (7). Two strains ofEscherichia coli, originally isolated from the blood of patients, 
were  maintained  on  blood  agar  plates  and  grown  overnight  in  brain  heart  infusion  broth. 
Before use,  they  were washed  twice and  resus,oended  in  medium.  1-2  ×  108  bacteria  were 
added to each macrophage monolayer culture. 
Fluorescence  Microscopy.  Some lymphocyte cultures were cytocentrifuged onto glass cover slips 
and  incubated  at 4°C sequentially with fluorescein-tagged goat anti-mouse/t-chain  antibody 
and rhodamine-tagged rabbit anti-rat thymocyte IgG. These preparations were examined with 
a  Leitz Orthoplan  fluorescence microscope (E.  Leitz, Inc., Rockleigh, N. J.)  equipped with a 
C5  100  W/2  mercury  vapor  lamp  (Philips  Electronic  Instruments,  Inc.,  Mahwah,  N. J.),  a 
Ploem epi-illumination system,  dichroic mirrors,  and  filters selective for fluorescein and  rho- 
damine (40). 
Generation of Experimental Supernates.  2  ×  106 nonelicited  (resident)  peritoneal  cells (~1  × 
106  macrophages)  or  1.25  ×  106  thioglycollate-elicited peritoneal  exudate  cells  (~1  ×  106 
macrophages)  were plated in culture dishes and incubated  for  1 h  at 37°C, after which dishes 
were washed  twice with medium  to remove nonadherent  cells. The  adherent  cell population 
(effector macrophages 3) was overlaid with fresh medium without  FBS; 0.2 ml of 0.5% E(IgG) 
was added to each macrophage monolayer and incubation continued for 4 h at 37°C. Cultures 
were then washed and noningested E lysed with NH4(21.5  ×  106 splenic or mesenteric lymph 
node  lymphocytes  in  either  medium  alone  or  medium-FBS  4 were  added  to  each  dish  and 
incubation continued for 24 h at 37°(2. Supernatant  medium from each culture was harvested, 
centrifuged at  750 g  for  10 min to remove cells and cellular debris,  and assayed  for its effect 
upon  macrophage  complement  receptor  function,  as  described  below.  Only  variations  from 
these standard  procedures are described in the text. 
Assessment of Supernatant Activity.  Cover slip cultures of freshly explanted, nonelicited mouse 
peritoneal  macrophages  were  incubated  in  either experimental  supernatant  media,  medium 
alone, or medium-20% FBS for 48 h  at 37°C, after which supernates and media were removed 
and cultures washed twice with fresh medium. The complement receptor activity of these assay 
macrophages was determined by incubating the monolayers with 0.2 ml of 0.5% E(IgM)C in 
fresh medium for 30 min at 37°C. Cultures were then washed and  fixed with glutaraldehyde; 
a Macrophages that were used in the generation ofsupernates will be referred to as effector macrophages; 
those  used  to assess the activity of supernates  will be referred  to as assay macrophages.  All experiments 
were performed  using both  thioglycollate-elicited and  nonelicited adherent  peritoneal  cells  as  effector 
macrophages.  Because the physiologic state of the effector macrophages did not substantially influence the 
activity of supernates,  results are presented without regard to the source of these cells. 
4 All experiments were performed using medium alone and  using medium-20%  FBS. There were no 
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E attachment and ingestion  were scored by phase contrast microscopic examination (7). 
Presentation of Results.  Each result  given represents the average of at  least  three separate 
determinations, each performed in duplicate. Attachment and phagocytic indices  (AI and PI) 
are the number of E attached (AI) or ingested  (PI) by 100 maerophages and were obtained by 
multiplying the percentage of macrophages that had attached or ingested any E by the average 
number of E attached or ingested per macrophage. Some results are presented as the percentage 
of the PI obtained under standard  conditions of supernate generation. In the Figures,  each 
result  is presented as mean ±  SEM. 
Results 
Ingestion of E(IgM)C by Supernate-treated Macrophages.  Our  initial  observation was 
that  macrophages treated  with  supernates  prepared  as  described  in  Materials  and 
Methods acquired the ability to ingest E(IgM)C. 59% of these macrophages ingested 
an average of 6.0 E(IgM)C each, for a PI of 354, whereas their nontreated counterparts 
ingested very few E(IgM)C (Table I). That ingestion of these E was due to enhanced 
C3b receptor function and not to the acquisition by supernate-treated macrophages 
of receptors  for either  E  themselves or another  immunologic component  on  the  E 
surface is also demonstrated by the results presented in Table I. Like their nontreated 
counterparts, supernate-treated macrophages did not bind or ingest either E, E(IgM), 
or E(IgM)C3d. 
Cellular Requirements for  the Generation of Supernatant Activity.  Supernates  were pre- 
pared  from cultures  containing  either macrophages, lymphocytes, or E(IgG) alone; 
from cultures  containing  only two of the three cell types;  from cultures  containing 
macrophages, lymphocytes, and anti-E IgG without E; and from cultures containing 
macrophages, lymphocytes, and  noncoated  E.  As shown  in Table II, none of these 
supernatant  preparations produced  a  significant  change  in  the assay macrophages' 
interaction with C3b-coated E. Thus, the generation of supernatant activity required 
interactions  between  effector macrophages  and  E(IgG)  and  subsequently  between 
these macrophages and lymphocytes. 
Effects of Low  Temperature and of Nonviable Cells upon the Generation and Expression of 
Supernatant Activity.  Supernates prepared from cultures containing either heat-killed 
macrophages (which had previously ingested E[IgG]) or heat-killed lymphocytes were 
inactive, as were supernates prepared from cultures in which lymphocyte-macrophage 
cocultivation was performed at 4°C (data not shown). In addition, assay macrophages 
that were incubated with active supernates at 4°C failed to ingest E(IgM)C (data not 
shown). These results suggest that both the generation and expression of supernatant 
activity require cellular metabolism. 
Effects of Varying Cell Numbers upon the Activity of Supernates.  Fig.  l a  records  the 
results obtained when the number of effector macrophages employed was varied from 
0 to 1 X  106 per culture. In Fig.  1 b, the number oflymphocytes employed was varied 
from  0  to  5  ×  106  per  culture.  Fig.  lc  records  the  results  obtained  when  the 
concentration of E(IgG) added in 0.2-ml aliquots to each culture was varied from 0 
to  0.5%.  The  activity  of supernates  generated  was  directly  dependent  upon  the 
concentration of each of the cell types used. 
Effects of Varying Incubation Times upon the Activity of Supernates.  As depicted  in Fig. 
2 a, the potency of supernates was directly proportional to the duration of incubation 
of effector macrophages  with  E(IgG).  Examination  of parallel  cultures  of effector 
macrophages cultivated on cover slips indicated that the number of E(IgG) ingested 658  ENHANCED MACROPHAGE COMPLEMENT  RECEPTOR  FUNCTION I. 
TABLE  I 
Interaction of Assay Macrophages with Various Preparations of Sheep E 
Particle 
added 
Nontreated macrophages  Supernate-treated macrophages 
AI*  PI*  AI  PI 
E  12  0  9  2 
E(IgM)  14  2  17  4 
E(IgM)C3d  15  3  14  7 
E(IgM)C3b  ~  1,200  4  ~  1,300  354 
* Calculated as described in Materials and Methods. 
TABLE II 
Cellular Requirements  for the Generation of Supernatant Activity 
Ceils present in supernate-generation steps 
Effector macro- 
E(IgG)  phages  Lymphocytes 
PI of E(IgM)C by 
assay macrophages 
+  +  +  397 
+  +  -  15 
+  -  -  12 
+  -  +  23 
-  +  +  16 
-  +  -  15 
-  -  +  10 
-  -  -  13 
Anti-E IgG*  +  +  32 
E only~  +  +  8 
* Anti-E IgG only (without E) was used. 
:~ Uncoated E were used. 
per macrophage increased with the duration of incubation (data not shown). These 
results  suggest  that  the  potency  of supernatant  activity  is  directly  related  to  the 
number of E(IgG) ingested by effector macrophages. 
The duration of lymphocyte-macrophage cocuhivation was also varied, from 0  to 
24 h  (Fig.  2b).  Maximally potent supernatant activity was  generated after  10  h  of 
lymphocyte-macrophage cocultivation. 
In  other  experiments,  the  duration  of  incubation of  assay  macrophages  with 
supernatant media was varied from 0 to 48 h. Assessment of the macrophages' ability 
to ingest E(IgM)C was always performed after 48 h of macrophage in vitro cultivation, 
and  supernates  were  always  present  at  the  48th  h  of  incubation.  For  example, 
macrophages which were exposed to supernates for 4 h were incubated in medium or 
medium-FBS from the time of explanation until the 44th h of in vitro cultivation and 
in  active  supernates  for  the  last  4  h.  As  demonstrated  in  Fig.  2c,  the  effect  of 
supernates upon macrophage complement receptor function was detected after 6 h of 
incubation, but  maximal effect  was  not achieved until after 48  h  of incubation of 
macrophages with supernates. 
Effect of Varying Concentrations of Supernates.  Varying dilutions of maximally effective 
supernates were prepared in medium or medium-FBS and their effect upon macro- 
phage complement receptor function assayed. As demonstrated in Fig. 3, supernates 
augmented macrophage complement receptor function in a  dose-dependent manner. JOHANNA  A.  GRIFFIN  AND  FRANK  M.  GRIFFIN,  Jr.  659 
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FIG.  l.  Effect  of varying cell numbers upon the activity of supernatant  media generated.  (a) The 
number  of effector  macrophages  was  varied  from  0  to  1  ×  10  6  per culture.  (b)  The  number  of 
lymphocytes was varied from 0 to 5  X  10  6 per culture.  (c) The percentage of E(IgG), added in 0.2- 
ml aliquots per culture, was varied from 0 to 0.5%. The percentage of standard  PI (ordinate)  is the 
percentage  of the  PI  obtained  when  the  numbers  of cells  used  to  generate  supernates  were  as 
described in Materials and Methods. 
Duration of Enhanced Macrophage Complement Receptor Function after Removal of Super- 
nates.  Assay  macrophages  that  had  been  incubated  for  48  h  at  37°C  in  active 
supernates  were washed,  overlaid with  fresh  medium,  and  incubated  at  37°C.  At 
varying times  thereafter, the  macrophages'  complement  receptor function was  as- 
sessed.  As shown in Fig. 4, the effect of supernates was quite transient;  the ability of 
macrophages to ingest E(IgM)C was reduced by 50% within 30 min and was virtually 
abolished within 4 h of removal of supernates. 
Effect of Phagocytosis of Various Particles upon the Macrophages' Ability to Participate in the 
Generation of Active Supernates.  The next group of experiments was designed to deter- 
mine whether phagocytosis of any particle by effector macrophages was sufficient to 
trigger the macrophage function necessary for the generation of active supernates or 
whether Fc receptor-mediated phagocytosis was required. 660  ENHANCED  MACROPHAGE COMPLEMENT  RECEPTOR  FUNCTION I. 
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FIG. 2.  Effect upon the generation and expression of supernatant activity of varying the duration 
of incubation of: (a) E(IgG) with effector macrophages, (b) effector macrophages with lymphocytes, 
and (c) assay macrophages in active supernatant media. The percentage of Standard PI (ordinate) 
is the percentage of the PI obtained when the incubation conditions were as described in Materials 
and Methods. 
Effector macrophages were  incubated  for 4  h  at  37°C  with  various particles and 
their  ingestion  determined  by  phase  contrast  microscopic examination  (Table  III, 
column 2). Group I  included polystyrene latex beads, E.  coli, and zymosan: particles 
that  are  ingested  by  means  not  known  to  involve  the  participation  of  specific 
phagocytic receptors. Group II included E(IgM)C and complement-coated zymosan: 
particles that  interact  with  macrophages  via the  macrophages'  C3  receptors;  these 
particles were  avidly bound  by nonelicited effector macrophages  (data not  shown) JOHANNA A. GRIFFIN AND FRANK  M.  GRIFFIN, Jr. 
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the entire volume of supernatant medium in one culture dish; other notations on the abscissa are 
dilutions of the neat supernate with medium-20% FBS. PI (ordinate) is the number of E(IgM)C 
ingested by 100 assay macrophages. 
100~ 
a" 
a  80 
E  ,< 
Q 
Z  60 
< 
I-- 
{/)  40  u. 
0 
20 
1  2  3  4  5  6 
(h)  AFTER  REMOVAL  OF 
ACTIVE  SUPERNATES 
Fro. 4.  Duration  of augmented  macrophage complement  receptor function after  removal of 
supernates. Assay macrophages were incubated  in active supernates for 48 h;  supernates were 
removed and macrophages were washed, covered with fresh medium, and placed at  37°C. At 
varying times thereafter, macrophage complement receptor function was assessed. The percentage 
of Standard  PI  (ordinate) is the  percentage of the  PI of macrophages treated  with supernates 
generated as described in Materials and Methods. 
and were readily ingested by thioglycollate-elicited effector macrophages. Group III 
included  sheep  E(IgG),  oxE(IgG),  and  IgG-coated  S.  pneumoniae:  particles  whose 
ingestion is mediated by the macrophages' Fc receptors. 
The supernatant media generated from cultures containing lymphocytes and these 
macrophages were assessed for their effect upon the complement receptor function of 
assay  macrophages;  the  results  are  presented  in Table III,  column 3.  Supernates 
generated from cultures containing macrophages that had phagocytized via nonim- 
munologic means (lines 1-3) or that had either bound or ingested particles via their 
complement  receptors  (lines  4  and  5)  were  without  effect  upon  the  complement 662  ENHANCED  MACROPHAGE COMPLEMENT RECEPTOR FUNCTION I. 
TABLE III 
Effect of Incubating Effector Macrophages with Various Particles upon the Macrophages'  Ability to 
Part#ipate in the Generation of Supernatant Activity 
PI of E(IgM)C  Particle incubated with effector  macro-  PI of test particle by  by assay macro- 
Group  phages  effector  macrophages  phages 
I  E. coli  1,400  11 
Latex beads  1,400  12 
Zymosan  750  22 
II  E(IgM)C  1,200  8 
Complement-coated  zymosan  900  18 
III  E(IgG)  1,300  360 
oxE(IgG)  1,260  351 
IgG-coated S. pneumoniae  1,400  158 
receptor  function  of assay  macrophages.  All  supernates  generated  from  cultures 
containing macrophages that had phagocytized !gG-coated particles (lines 6-8), on 
the  other  hand,  exerted  a  striking  effect upon  macrophage  complement  receptor 
function. 
These results demonstrate that the stimulus for the effector macrophages' partici- 
pation  in  the  generation  of active supernates  is  not  phagocytosis per se,  but  that 
phagocytosis via the cells' Fc receptors is both the necessary and sufficient trigger for 
these macrophages to interact with lymphocytes to produce a factor(s) that enhances 
the complement receptor function of assay macrophages. 
Soluble Immune  Complexes Can Substitute for IgG-coated Particles in  Triggering the Macro- 
phage  Function Required for the  Generation of Supernatant Activity.  Two types of soluble 
IgG-containing material,  heat-aggregated IgG, which has been previously found to 
mimic  soluble  immune  complexes in  many  respects  (34,  41),  and  HSA-anti-HSA 
complexes, were used in place of IgG-coated particles to engage Fc receptors of effector 
macrophages. Control macrophage cultures received either nonaggregated IgG, anti- 
HSA  antiserum  alone,  or  HSA  plus  nonimmune  rabbit  serum.  Supernates  from 
cultures containing macrophages that  had been fed either aggregated IgG or HSA- 
anti-HSA  complexes were  as  active  as  those  prepared  using  IgG-coated  particles, 
whereas all control supernates were inactive (Fig. 5). Thus, either soluble or particulate 
IgG-containing immune complexes can trigger effector macrophages to perform their 
function in the generation of supernatant activity. 
The Activity  of Supernates Is Dependent upon the Number of Effector Macrophage Fc Receptors 
Engaged  by  IgG Molecules.  The  following experiments were  designed  to  determine 
whether the quantity of IgG contained in ingested immune complexes, or the number 
of IgG-coated particles phagocytized by effector macrophages, regulated the activity 
of supernates. Here we took advantage of the finding of Ehlenberger and Nussenzweig 
(9)  that the number of IgG molecules required to trigger the ingestion of a  particle 
coated with both IgG and C3b molecules is much less than the number required for 
ingestion of a  particle coated with only IgG. E(IgM)C were incubated with varying 
quantities  of anti-E  IgG,  the  greatest  quantity  used  (5  /tl/ml)  being  the  amount 
normally used to prepare E(IgG). These complement- and IgG-coated E  were then JOHANNA  A.  GRIFFIN AND FRANK M.  GRIFFIN, Jr. 
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Fro.  5.  Effect of ingestion of aggregated IgG and  of soluble immune complexes by effector 
macrophages upon the activity of supernates. Either 2 mg of aggregated rabbit (agg) IgG,  soluble 
HSA-anti-HSA complexes  containing 2 mg of HSA, or a control preparation was substituted for 
E(IgG) as the material fed to effector macrophages. Other conditions of supernate generation and 
assay were as described in Materials and Methods. The percentage of Standard PI (ordinate) is the 
percentage of the PI of macrophages treated with supernates generated as described in Materials 
and Methods. NI serum, nonimmune rabbit serum; nonagg IgG,  nonaggregated rabbit IgG. 
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incubated with effector macrophages (both thioglycollate-elicited and nonelicited) for 
4 h  at 37°C. Thioglycollate-elicited macrophages ingested all E preparations equally 
well, ingestion being mediated via both Fc and C3b receptors presumably. Nonelicited 
macrophages ingested equally well E prepared with 5, 2.5, and  1 #l/ml of anti-E IgG, 
but ingested E prepared with 0.5 and 0.1 ttl/ml much less avidly (Fig. 6a). 
These macrophages, which had ingested E  coated with varying quantities of anti- 
E IgG, were cocultivated with lymphocytes for 24 h at 37°C to prepare experimental 
supernates. The activity of supernates was directly dependent  upon the quantity of 
anti-E IgG on the E surface and independent of the number of IgG-coated E ingested 
(Fig. 6 b). Thus, the number of effector macrophage Fc receptors engaged by particle- 
bound IgG regulates the activity of supernatant  media. The number of IgG-coated 
particles ingested appears to be important only insofar as it reflects the number of Fc- 
Fc receptor interactions. 
Ident~'cation  of  the  Lymphocytes that  Participate  in  the  Generation  of  Supernatant 
Activity.  When either thymocytes or T-lymphocyte-enriched spleen cell preparations 
were used in place of nonfractionated  splenic lymphocytes, the resulting supernates 
were active (Table IV). However, supernates prepared from cultures in which either 
B  lymphocyte-enriched  spleen  cells  or splenic  lymphocytes from  athymic  (nu/nu) 
mice were used were inactive (Table IV). These results indicate that T  lymphocytes 
perform the necessary and sufficient lymphocyte function in the generation of active 
supernates. 
Identification of the Cell Type that Elaborates the Active Principle.  Effector macrophages 
that had ingested E(IgG) were incubated with thymocytes at 37°C for 12 h, at which 
time  thymocytes were  aspirated,  washed,  adjusted  to  5  ×  106  cells  per culture  in 
medium  or  medium-FBS,  and  incubated  alone  for  12  h  at  37°C.  The  effector 
macrophages from these cultures were washed, treated with anti-Thy-1 antiserum and 
complement to remove remaining thymocytes, covered with fresh medium or medium- 
FBS, and incubated for 12 h at 37°C.  Examination of parallel cultures revealed that 
treatment with anti-Thy-1  antiserum and complement removed contaminating thy- 664  ENHANCED MACROPHAGE COMPLEMENT  RECEPTOR  FUNCTION I. 
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FIe.  6.  Effect of the quantity of IgG on the particle ingested  by effector macrophages upon the 
activity of supernates.  E(IgM)C  were prepared  as  described  in  Materials  and  Methods.  These 
E(IgM)C were then incubated with varying quantities of anti-E IgG. The resulting E(IgM)C-(IgG) 
were incubated for 4 h with either nonelicited (0) or thioglycollate-elicited (A) effector macrophages. 
Ingestion of these  E  by effector  macrophages  is  recorded  in  (a). Other conditions of supernate 
generation were as described  in Materials and Methods. Supernatant  medium from each of these 
cultures was then assessed for its effect upon the complement receptor function of normal macro- 
phages  (b). 
mocytes  and  that  macrophages  in  these  cultures  remained  morphologically  intact, 
excluded  trypan  blue  dye,  and  were  able  to  phagocytize  normally.  The  thymocyte 
and  macrophage  supernates  were then  tested  separately  for their ability  to augment 
macrophage  complement  receptor function. Thymocyte  supernates were 92 +_  10% as 
active  as  those  prepared  in  the  standard  fashion.  Supernates  from  macrophage 
cultures, on the other hand,  were completely inactive. Therefore, T  lymphocytes, but 
not  macrophages,  elaborate  the active principle. 
Requirement for  Macrophage-T  Lymphocyte Contact  in  the  Generation of Active  Super- 
nates.  Macrophages  and lymphocytes have been reported to interact in both contact- JOHANNA A.  GRIFFIN AND FRANK M.  GRIFFIN, Jr. 
TABLE  IV 
Effect of Lymphocyte Subpopulations upon the Generation of Supernatant Activity 
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Lymphocytes  Percentage of 
Source  Treatment  B ceils  T cells 
Percentage of 
standard PI 
Spleen  --  43 
Spleen  E(IgG)C  rosetted  (Ficoll-Hypaque  10 
pellicle) 
Thymus  --  2 
Spleen  Anti-Thy-l-antiserum  +  comple-  97 
ment 
Athymic  (nu/nu)  --  90 
mouse spleen 
% 
53 
66 
89 
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Fie.  7.  Effect  of lymphocyte-macrophage contact  upon  the generation of supernatant  activity. 
Experimental  supernates  were  generated  as  described  in  Materials  and  Methods  (bar  A).  Fc 
receptor-triggered macrophages  were cultivated for  12  h  at  37°C,  after which  thymocytes were 
incubated  for  12 h  at  37aC  in the macrophage culture supernates  (bar B). Thymocytes and  Fc 
receptor-triggered effector macrophages were separated by (C) or were overlaid with (D) a Millipore 
filter (0.22-ttm pore size). In (E), supernates prepared as described in Materials and Methods were 
preincubated  with  Millipore filters  for  2  h  at  37°C before transfer  to assay  macrophages.  The 
activity of each supernate was assessed as described in Materials and Methods. 
dependent  and  contact-independent  manners  to  modulate  the  functions  of either or 
both  cell  types  (14-33,  39,  42-57).  To  understand  better  the  mode  of interaction 
between these two cell types in the generation of active supernates,  we performed the 
following experiments. 
Effector macrophages  that  had ingested oxE(IgG) were incubated  alone for  12 h  at 
37°C,  and  the supernatant  media harvested.  Freshly harvested  thymocytes  (5  ×  106 
per  culture)  were  incubated  in  these  supernates  for  12  h  at  37°C,  after  which  the 
culture supernates  were tested  for their ability to augment  macrophage  complement 
receptor  function.  As  shown  in  Fig.  7,  bar  B,  these  supernates  were  inactive.  These 
results suggest  that  effector macrophages  may signal T  lymphocytes  to elaborate  the 
active principle by a  contact-dependent  mechanism  rather than by means of a  soluble 666  ENHANCED  MACROPHAGE COMPLEMENT RECEPTOR FUNCTION I. 
macrophage mediator. However, because it was possible that, in these experiments, a 
soluble macrophage mediator may have been generated but subsequently degraded 
during the initial  12-h incubation, the necessity for lymphocyte-macrophage contact 
was further examined in the following experiments. 
Effector macrophages were fed oxE(IgG). Each macrophage monolayer was then 
gently covered with a  Millipore filter (Millipore Corp., Bedford, Mass.)  of 0.22-#m 
pore  size,  5  ×  106  thymocytes were  added  to  each  culture  dish,  and  incubation 
continued for 24 h at 37°C. To be certain that the Millipore filters had not crushed 
or otherwise injured the macrophage monolayers, parallel cultures were examined by 
phase contrast microscopy after incubation with trypan blue dye. The morphology of 
the macrophages was normal, and >98% of the cells excluded the dye. The supernatant 
media were aspirated, freed of thymocytes and cellular debris by centrifugation, and 
assayed for their effect upon macrophage complement receptor function. As shown in 
Fig. 7, bar C, supernates prepared in this fashion were inactive. To be certain that the 
Millipore filters had not simply absorbed the activity from these supernates, identical 
experiments were performed in  which  lymphocytes and  macrophages were coculti- 
vated  with  Millipore  filters  overlying  the  cells,  and  supernates  generated  in  the 
standard  fashion  were  preincubated with  Millipore  filters  for 2  h  at  37°C  before 
transfer to assay macrophages.  Supernates  prepared  and  treated  in  these  manners 
were as active as standard  supernates  (Fig.  7,  bars D  and  E).  Although  it  remains 
possible that effector macrophages may exert their effect upon lymphocytes by means 
of a  very labile  soluble  mediator,  these  results  strongly  suggest  that  lymphocyte- 
macrophage contact is necessary for the generation of supernatant activity. 
Is  the  Interaction  between Lymphocytes  and  Macrophages  Histcompatibility  Restric- 
ted?  Contact between lymphocytes and macrophages has been found to be necessary 
for thymocyte maturation  (50,  57),  for maximal T-cell proliferation in  response to 
macrophage-bound  antigen  (48,  49,  53,  55),  for  the  generation  of carrier-specific 
helper T  cells (45), for the production of lymphokines by T  and B lymphocytes (33), 
and  for  IgG  production  by  lymphocytes  (42-44,  46).  In  most  of these  examples, 
macrophages and lymphocytes can cooperate only when they share certain histcom- 
patibility specificities. In  fact, in some experimental systems, efficient macrophage- 
lymphocyte contact  does not  occur unless  the cells  involved are  identical  at  the  I 
region of the H-2 complex. Because lymphocyte-macrophage contact appears to be 
required in our system, it was of interest to determine whether or not the collaboration 
of the two cell types was histocompatibility restricted. 
Thymocytes and  macrophages  from  BALB/c  (H-2  d)  and  C57BL/6  (H-2  b)  mice 
were cocultivated for 24 h  at 37°C in all possible combinations; some macrophages 
had previously ingested E(IgG). The activity of each culture supernate was assessed 
using  assay  macrophages  from  both  BALB/c  and  C57BL/6  mice.  As  depicted  in 
Table  V,  cultivation  of allogeneic  thymocytes  with  macrophages  that  had  not 
phagocytized did not result in the elaboration of supernatant activity by thymocytes, 
indicating that, at least under the culture conditions employed, recognition of foreign 
histocompatibility  antigens  by  lymphocytes was  not  a  sufficient  stimulus  for  the 
production and/or release of the active principle. Supernates from all cultures which 
contained thymocytes cocultivated with macrophages which had previously ingested 
E(IgG), however, were active regardless of the source of either cell type. These results 
indicate that there is no histocompatibility restriction involved in the cell-cell coop- JOHANNA  A.  GRIFFIN  AND  FRANK  M.  GRIFFIN,  Jr. 
TABLE  V 
Lack of Histocompatibility Restriction in the Generation of and Response to 
Active Supernates 
H-2 Type 
Effector macro-  PI of E(IgM)C by 
Assay macro-  assay macrophages 
phages  Lymphocytes  phages 
d*  b  d  38 
d*  b  b  41 
b*  d  d  22 
b*  d  b  41 
667 
d  d  d  335 
d  d  b  205 
d  b  d  350 
d  b  b  399 
b  d  d  413 
•  b  b  d  308 
b  d  b  371 
b  b  b  265 
* Effector macrophages were not previously incubated with E(IgG). 
eration  required  for the  generation  of active supernates  and  that  the  response  to 
supernatant  activity  is  not  dependent  upon  histocompatibility  between  the  cells 
generating the activity and the cells responding to it. 
Discussion 
Peritoneal  macrophages  from  mice  that  had  been  injected  with  thioglycollate 
medium were previously reported to ingest E(IgM)C (8). Because injection of thiogly- 
collate medium into the mouse peritoneal cavity may have induced the influx of a 
population of mononuclear phagocytes with enhanced complement receptor activity, 
it could not be concluded from those studies that the complement receptor function 
of resident peritoneal macrophages had been, or could be, augmented. Results of the 
present experiments demonstrate that  tissue macrophages can be induced to ingest 
particles via their complement receptors. 
Induction of this property in macrophages was effected by a product(s) in supernates 
of cultures containing lymphocytes and specifically triggered macrophages. Several 
hours were required for both the generation and the expression ofsupernatant activity. 
Activity was generated when lymphocytes and macrophages interacted at physiologic 
temperature but  not  when  the cells were cocultivated at  4°C.  These initial  results 
indicated that the activity assayed did not derive from nonspecific cellular metabolites 
or from alterations in  trivial experimental conditions such as pH, tonicity, protein 
content, or ion concentration of the incubation media. Rather, they strongly suggested 
that  either cellular metabolism,  temperature-dependent cell-surface interactions, or 
both were required for the generation of the active product(s). Subsequent experiments 
revealed that both cellular metabolism and lymphocyte-macrophage surface interac- 
tions were required, for effector macrophages had first to phagocytize IgG-containing 
immune complexes and then to interact by a contact-dependent mechanism with T 
lymphocytes in order to signal the lymphocytes to elaborate the activity assayed. 668  ENHANCED  MACROPHAGE COMPLEMENT RECEPTOR FUNCTION I. 
Attachment and ingestion of particles by phagocytic cells are known to modulate 
several cellular functions, some of which are directly related to killing or degrading 
the ingested material. For example, phagocytizing macrophages synthesize increased 
quantities of lysosomal hydrolases (58); and neutrophils and macrophages are stimu- 
lated  by  the  act  of phagocytosis  or  by  interaction  of certain  plasma  membrane 
receptors with appropriate ligands to release lysosomal enzymes and to increase their 
rates of oxygen uptake and metabolism (41, 59). Certain other macrophage functions, 
which do not appear to be related to the disposal of ingested material, may also be 
augmented by phagocytosis. Phagocytosis is a  potent inducer of monocyte synthesis 
and secretion of endogenous pyrogen (60).  Gordon et al.  (61)  found that endotoxin- 
elicited mouse peritoneal macrophages were triggered to secrete plasminogen activator 
when the cells ingested either polystyrene latex beads or bacteria, and phagocytosis 
was  subsequently  found  to  trigger  the  synthesis  and  secretion  of collagenase  and 
elastase as well (62, 63). Unanue et al. (31) have shown that macrophages are induced 
by the act of phagocytosis to release a factor(s) that influences the behavior of both T 
and B lymphocytes. In contrast to our findings, however, induction of the macrophage 
property examined in each of these studies, although dependent upon phagocytosis, 
was independent of the means by which phagocytosis occurred. 
That the metabolic events associated with phagocytosis of a particle by one type of 
plasma  membrane  receptor  may  be  quite  different  from  events  associated  with 
ingestion of a  particle by a  different means  is  suggested  by recent work from two 
laboratories. Michl et al. (64) found that 2-deoxy-D-glucose blocked immunologically 
mediated phagocytosis by macrophages but had  no effect upon the cells' ability to 
ingest  particles  via  nonimmunologic  means.  Muschel  et  al.  (65)  found  that  the 
ingestion of IgG-coated E, but not of latex particles, could be modulated by treating 
macrophages  with  insulin  or cyclic AMP.  Because  the  physiology of phagocytosis 
varies depending upon the route by which a particle is phagocytized, it would not be 
surprising  if different  routes  of ingestion  were  to  regulate  different  macrophage 
functions. Yet  there are  only rare  instances  in  which  such  functional selectivity is 
known to occur. Rickettsia mooseri (66), Toxoplasma gondii (67), and vaccinia virions (68) 
are  readily  ingested  by  macrophages,  but  only  microorganisms  that  have  been 
pretreated with  immune  serum  are  killed  intracellularly.  In  these cases,  lysosomal 
fusion with phagosomes appears  to be dependent  upon the  interaction of particle- 
bound IgG with the macrophage, presumably via the cell's Fc receptors. Our results 
strengthen the hypothesis that  metabolic events induced by phagocytosis of immu- 
nologically  coated  particles  are  different  from  those  induced  by  phagocytosis  of 
noncoated particles.  They also  demonstrate  that  metabolic events  triggered  by Fc 
receptor-mediated phagocytosis are different from those triggered by C3b receptor- 
mediated phagocytosis, for ingestion via the macrophages' complement receptors was 
not a sufficient stimulus for the effector macrophages' participation in the generation 
of supernatant activity. 
The  lymphocyte that  participates  in  the  generation  of supernatant  activity was 
shown  to  be  the  T  lymphocyte. Both  thymocytes and  T-cell-enriched lymphocyte 
preparations were as effective as whole spleen cell populations, whereas B lymphocyte- 
enriched preparations were ineffective. In subsequent experiments, we found that the 
T lymphocyte was the cell which elaborated the active principle, for when thymocyte- 
macrophage cultures were split after 12 h of cocuhivation and the cell types cultivated JOHANNA A. GRIFFIN AND FRANK M. GRIFFIN, Jr.  669 
separately, only thymocyte supernates were able to augment macrophage complement 
receptor function. In addition, treatment of thymocytes with concanavalin A resulted 
in the appearance in culture supernates of a similar activity (J. A. Griffin and F. M. 
Griffin, unpublished observation). These findings are consistent with the findings of 
many other investigators that  most mediators that  influence macrophage behavior 
are elaborated by T  lymphocytes (16). 
The results  of experiments in  which  thymocytes were incubated  in  supernatant 
media from cultures containing Fc receptor-triggered macrophages and of  experiments 
in which lymphocytes and macrophages were cocuhivated in the same dish but were 
separated by a Millipore filter strongly suggest that lymphocyte-macrophage contact 
is required for macrophages to induce lymphocytes to elaborate the active material. 
Several investigators have previously shown that lymphocyte-macrophage contact is 
required for macrophages to exert certain effects upon T  lymphocytes. Werdelin et al. 
(51),  Nielson  et  al.  (52),  and  Braendstrup  et  al.  (53)  have  shown  that  intimate 
association occurs between sensitized T  lymphocytes and macrophages in the presence 
of appropriate antigen and that physical contact is required for optimal lymphocyte 
blastogenesis to occur. Lipsky and Rosenthal (54-56) also demonstrated that macro° 
phage-T lymphocyte contact is required for lymphocytes to respond to macrophage- 
bound antigen and further showed that the two cell types must be histocompatible. 
Van  den  Tweel  and  Walker  (57)  have  recently shown  that  thymocytes  undergo 
mitogen-induced blastogenesis only after being cocultivated with macrophages; mac- 
rophage-thymocyte contact appeared to be required but did not occur via histocom- 
patibility  antigens,  because  allogeneic,  as  well  as  autologous,  macrophages  were 
capable of imparting to thymocytes enhanced mitogen responsiveness. In our system, 
also, the requirement for lymphocyte-macrophage contact was independent of histo- 
compatibility, for cells from mice with  completely different H-2 specificities could 
cooperate to produce the activity. Therefore, although lymphocyte-macrophage con- 
tact  is  required  for  the  generation  of active  supernates,  the  cellular  interactions 
probably occur via  surface  moieties  not  encoded  by  the  major  histocompatibility 
complex. 
Possible Physiologic Significance of Complement Receptor-Mediated Phagocytosis by Macro- 
phages.  It is becoming increasingly apparent that the cellular and humoral limbs of 
the immune system are not functionally separate entities. We have described in vitro 
conditions wherein these limbs may be tightly interwoven in a cyclic amplification of 
the function of each by the other. The phenomena described may occur in vivo and 
may have implications in the areas of inflammation, host defense against  microbial 
pathogens, immune complex disease, and neoplasia. 
The ability of macrophages  to  ingest  via  their complement  receptors a  particle 
coated with both IgG and C3b molecules may be advantageous, for in vivo phagocytic 
cells  are  bathed  in  IgG,  which  can  adsorb  to  their  Fc  receptors  and  which,  at 
concentrations less than those found in serum and tissue fluid, can impair the cells' 
ability to ingest IgG-coated particles in vitro (2, 5, 69).  In addition, many microor- 
ganisms  shed  antigens  which  become bound  by specific IgG;  when  these  immune 
complexes are  ingested by macrophages,  the cells' ability to ingest  the IgG-coated 
microbe by their Fc receptors may then be further impaired  (70). The formation of 
immune complexes by shed microbial antigens and specific IgG may also diminish 
the quantity of antibody available to opsonize the microbe. Because most microor- 670  ENHANCED  MACROPHAGE COMPLEMENT  RECEPTOR  FUNCTION I. 
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FIG. 8.  Model for the possible significance of enhanced macrophage complement receptor function 
in: (a) host defense against microbial pathogens,  (b) host cell injury in immune  complex disease, 
and  (c) destruction  of neoplastic cells. Sequence  (a):  (step I)  macrophages  ingest shed bacterial 
antigen-lgG complexes ('i~-),  thereby (step II) acquiring the ability to interact with T lymphocytes 
such that (Step III) T cells elaborate the lymphokine which (step IV) permits macrophages to ingest 
C3b (a)-coated bacteria.  Sequence  (b):  (step I) macrophages  ingest soluble immune  complexes 
('K') and thereby (step II) acquire the ability to interact with T lymphocytes such that (step III) T 
cells elaborate the lymphokine that (step IV) permits macrophages to damage host cells which are 
innocently coated with C3b at sites of inflammation.  Sequence (c) : neoantigens of malignant cells 
become bound by specific IgG (1), and C3b is deposited over thecells' surfaces. The neoplastic cells 
cap neoantigen-IgG complexes. Macrophages bind to neoplastic cells via the complexes and (step I) 
ingest the caps, thereby (step II) acquiring the ability to interact with T  iymphocytes such that 
(step III) T cells elaborate the lymphokine which (step IV) permits macrophages to damage the 
C3b-coated neoplastic cells. 
ganisms have  surface moieties, e.g., polysaccharide or lipopolysaccharide, which  fix 
complement  via the alternative pathway, they become coated with C3b  even when 
not coated with antibody (71). Macrophages, having ingested microbial antigen-IgG 
complexes,  could  trigger  T  lymphocytes  to  secrete  the  lymphokine  that  enhances 
macrophage complement receptor function. As a  result, macrophages in the vicinity 
of these lymphocytes would acquire the ability to ingest the C3b-coated microorga- 
nisms (Fig. 8, sequence a). 
A  similar sequence of events may occur in immune complex diseases and result in 
host cell damage  (Fig. 8,  sequence  b).  Macrophages  that  ingest  immune  complexes 
may interact with T  lymphocytes, resulting in the elaboration of a product that alters 
the macrophages'  interaction  with  C3b-coated cells. Host  cells which  have  become 
innocently coated with C3b at sites of immune complex-induced inflammation may 
then be attacked by these macrophages, either by phagocytosis or by enhanced release 
of lysosomal enzymes, superoxide anion, or hydrogen peroxide. Rapid reversal of the 
effect upon macrophage complement receptor function after dissipation of the active 
product, which would occur when inflammation had been sufficiently cleared, would 
serve as a  control mechanism to prevent continued destruction of host tissues. JOHANNA A. GRIFFIN AND FRANK M.  GRIFFIN, Jr.  671 
Finally, our findings may be pertinent to tumor cell destruction by macrophages 
(Fig.  8,  sequence c).  Many  neoplastic  cells  express on  their  surfaces  antigens  not 
present on normal cells (72, 73). Host antibody to these antigens is elicited and binds 
specifically to  these  neoantigens;  in  addition,  complement  components,  including 
C3b,  are  subsequently deposited over the  cells' surfaces.  Some neoplastic cells are 
capable of capping cell surface immune complexes (74). We have shown  (39)  that 
macrophages can phagocytize capped immune complexes from the surfaces of some 
cells without harming the cells. In the case of a neoplastic cell, such a series of events 
would  result  in  a  cell  diffusely coated  with  C3b  but  with  neither  antibody  nor 
abnormal determinants on its surface. Normal macrophages would be able to bind to 
the C3b-coated cell, but would not ingest it, and would probably release the cell when 
C3b inactivator cleaved C3b to C3c and C3d. Schreiber and Frank (75) have shown 
that the interaction of normal macrophages with C3b-coated E  does not result in E 
damage; it is likely that a similar interaction of normal macrophages with C3b-coated 
tumor cells would likewise not harm the cells. However, the ingestion by macrophages 
of immune complexes from the surface of a tumor cell may permit the macrophages 
to trigger T  lymphocytes to elaborate a  product that  permits these or other macro- 
phages to interact more aggressively with C3b-coated cells. These macrophages may 
then be able to destroy C3b-coated tumor cells, either by phagocytosis and intracel- 
lular killing or by extracellular cytotoxic mechanisms. 
Summary 
The  function  of complement  receptors  of  mouse  peritoneal  macrophages  was 
converted in vitro from mediating only attachment, to promoting both attachment 
and  ingestion  of C3b-coated  particles.  Enhancement  of macrophage  complement 
receptor  function  was  achieved  by  treating  freshly  explanted  macrophages  with 
supernates  from  cultures  containing  T  lymphocytes  and  appropriately  triggered 
macrophages.  Fc receptor-mediated phagocytosis by macrophages was  required for 
the production of active supernates,  for neither ingestion via the cells' complement 
receptors nor ingestion via nonimmunologic means was a  sufficient stimulus for the 
macrophages'  participation  in  the  generation of supernatant  activity.  Fc receptor- 
triggered  macrophages  interacted  by  a  contact  dependent,  but  histocompatibility 
independent, mechanism with T  lymphocytes, thereby signalling the lymphocytes to 
elaborate  the  active  product.  The  possible  significance  of enhanced  macrophage 
complement receptor function in inflammation, host defense against microbial path- 
ogens, immune complex disease, and neoplasia is discussed. 
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